- Home
- SYRE vs TRNO Comparison
SYRE vs TRNO Comparison
Compare SYRE & TRNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SYRE | TRNO |
|---|---|---|
| Founded | 2013 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 7.0B |
| IPO Year | 2015 | 2009 |
Fundamental Metrics
Financial Performance| Metric | SYRE | TRNO |
|---|---|---|
| Price | $96.64 | $66.38 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 19 |
| Target Price | ★ $122.53 | $73.59 |
| AVG Volume (30 Days) | ★ 1.1M | 672.3K |
| Earning Date | 11-03-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 3.35% |
| EPS Growth | N/A | ★ 103.65 |
| EPS | N/A | ★ 1.81 |
| Revenue | N/A | ★ $476,383,000.00 |
| Revenue This Year | N/A | $7.40 |
| Revenue Next Year | N/A | $12.07 |
| P/E Ratio | ★ N/A | $57.13 |
| Revenue Growth | N/A | ★ 24.51 |
| 52 Week Low | $21.15 | $57.95 |
| 52 Week High | $110.18 | $78.94 |
Technical Indicators
Market Signals| Indicator | SYRE | TRNO |
|---|---|---|
| Relative Strength Index (RSI) | 60.94 | 63.88 |
| Support Level | $93.45 | $63.59 |
| Resistance Level | $105.09 | $69.64 |
| Average True Range (ATR) | 4.29 | 1.35 |
| MACD | 1.22 | 0.36 |
| Stochastic Oscillator | 93.81 | 98.16 |
Price Performance
Historical ComparisonAbout SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About TRNO Terreno Realty Corporation
Terreno Realty Corp is a real estate investment trust engaged in acquiring, owning, and operating industrial real estate in six coastal U.S. markets: Los Angeles, Northern New Jersey/New York City, San Francisco Bay Area, Seattle, Miami, and Washington, D.C. The company invests in several types of industrial real estate, including warehouse/distribution, flex (including light industrial and research and development), transshipment, and improved land.